CD34 and acute lymphoblastic leukemia: A retrospective study analyzing 101 adult allo-HSCT ALL patients undergoing chimerism monitoring by multiplex STR assay (sensitivity 10-2), showed that an increasing mixed chimerism in CD34+ BM cells was an independent negative prognostic factor for OS and relapse in multivariable analysis (84).